(PRTA) Prothena - Performance -68.2% in 12m
PRTA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-43.06%
#57 in Peer-Group
Rel. Strength
5.04%
#7288 in Stock-Universe
Total Return 12m
-68.24%
#160 in Peer-Group
Total Return 5y
-39.75%
#53 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 64.1 |
| High / Low | USD |
|---|---|
| 52 Week High | 24.79 USD |
| 52 Week Low | 4.58 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 94.57 |
| Buy/Sell Signal +-5 | 0.67 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: PRTA (-68.2%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.72% | -1.16% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: PRTA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PRTA
| Total Return (including Dividends) | PRTA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 31.86% | 3.36% | 4.68% |
| 3 Months | -40.75% | 15.73% | 24.35% |
| 12 Months | -68.24% | -7.02% | 14.02% |
| 5 Years | -39.75% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | PRTA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 94.4% | 4.4% | 81% |
| 3 Months | -83.2% | 78.8% | 96.9% |
| 12 Months | -94.5% | -85.8% | 44.9% |
| 5 Years | -13.6% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th91.50 | 27.58% | 25.29% |
| 3 Month | %th5.00 | -48.80% | -52.26% |
| 12 Month | %th21.00 | -65.84% | -72.18% |
| 5 Years | %th75.00 | -20.50% | -71.56% |
FAQs
Does Prothena (PRTA) outperform the market?
No,
over the last 12 months PRTA made -68.24%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months PRTA made -40.75%, while XBI made 15.73%.
Performance Comparison PRTA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PRTA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.6% | 27.2% | -56.7% | -82% |
| US NASDAQ 100 | QQQ | 4.4% | 26.6% | -57.4% | -81% |
| German DAX 40 | DAX | 6.3% | 33.3% | -68.9% | -97% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.1% | 28.5% | -60.1% | -89% |
| Hongkong Hang Seng | HSI | 4.5% | 25.8% | -76.2% | -107% |
| India NIFTY 50 | INDA | 6% | 28.4% | -57% | -67% |
| Brasil Bovespa | EWZ | 1.7% | 23.1% | -81.8% | -78% |
PRTA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.5% | 26% | -60.9% | -93% |
| Consumer Discretionary | XLY | 4.6% | 28.7% | -49.1% | -86% |
| Consumer Staples | XLP | 3.8% | 31.2% | -58.4% | -77% |
| Energy | XLE | 3.8% | 24.8% | -52.6% | -68% |
| Financial | XLF | 3.4% | 26.8% | -61.6% | -98% |
| Health Care | XLV | 4.7% | 29.7% | -49.4% | -64% |
| Industrial | XLI | 4.1% | 27.7% | -64.6% | -93% |
| Materials | XLB | 1.9% | 27.6% | -61.2% | -74% |
| Real Estate | XLRE | 4.2% | 30.9% | -56.4% | -81% |
| Technology | XLK | 3.4% | 23.2% | -59.1% | -79% |
| Utilities | XLU | 5.2% | 30.1% | -60% | -91% |
| Aerospace & Defense | XAR | 6.3% | 24.8% | -75.3% | -118% |
| Biotech | XBI | 3.2% | 28.5% | -43.5% | -61% |
| Homebuilder | XHB | 1.6% | 24.8% | -49.6% | -74% |
| Retail | XRT | 1.6% | 26.9% | -52.4% | -80% |
PRTA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.2% | 23.4% | -48.3% | -61% |
| Natural Gas | UNG | 13.6% | 41.7% | -39.9% | -66% |
| Gold | GLD | 3.9% | 33.1% | -77.4% | -107% |
| Silver | SLV | 3.1% | 24.9% | -74.1% | -86% |
| Copper | CPER | 5% | 26.3% | -73.8% | -80% |
PRTA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 6% | 30.8% | -53.3% | -66% |
| iShares High Yield Corp. Bond | HYG | 5.3% | 30.3% | -55.6% | -78% |